JAMA Dermatology

Article	Citations
JAMA Dermatology	835
Perceptions of US-Based Muslim Patients of Their Dermatology Care	393
Treatment of Verruca Plana With Topical Combination of Calcipotriol and Fluorouracil	244
Error in Author Name	163
Error in Author Surname in Byline	157
Widespread Erythematous Plaques With Prominent Telangiectases	142
Treatment With Topical Sirolimus for Recurrent Lymphatic Malformation of the External Urethral Meatus	132
Clinical and Pathological Spectrum of Prurigo Pigmentosa in Central European Individuals	126
Frequency of Skin Biopsies for Psoriasis by Race and Ethnicity	114
JAMA Dermatology	107
Exanthematous Eruption in a Patient With Known Chronic Graft-vs-Host Disease and Recent Measles Vaccination	107
Melanoma Screening	101
Can Serum Biomarkers for Prurigo Nodularis Expose Pathophysiology or Just Treatment Response?	90
Recurrence Rate of Melanoma In Situ Excised With a 5-mm Excisional Margin	89
Treatment of Kimura Disease With Dupilumab	85
Immune Checkpoint Inhibitors in Field Cancerization and Keratinocyte Cancer Prevention	83
Smoking Cessation and Risk of Hidradenitis Suppurativa Development	82
Tofacitinib for Treatment of Acquired Reactive Perforating Collagenosis	77
Association of Treatment With Secukinumab With Exacerbation of Dermatomyositis in a Patient With Psoriasis	74
Outcomes Associated With Combination Shaving and Cryosurgery Treatment in Patients With Keloid Scars	73
Cutaneous Angiosarcoma	64
Subclinical Synovitis Among Patients With Psoriasis Without Musculoskeletal Involvement	63
Patient-Reported Outcomes in Dermatology	62
Group Omitted From Article Byline	62
Ultraprocessed Food Intake and Psoriasis	61

Alopecia Areata	58
Pregabalin for Neuropathic Pain and Itch in Recessive Dystrophic Epidermolysis Bullosa	57
Parental E-Cigarette Use and Pediatric Atopic Dermatitis	56
Skin Cancer Care in US Veterans—Serving Those Who Served	54
Treatment With Ataluren for Wound Healing and Health Complications in a Patient With Junctional Epidermolysis Bullosa	52
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice	51
Prevalence of Contact Allergens in Natural Skin Care Products From US Commercial Retailers	50
Biomarkers of Tretinoin Precursors and Tretinoin Efficacy in Patients With Moderate to Severe Facial Photodamage	50
Association of Persistent Rubella Virus With Idiopathic Skin Granulomas in Clinically Immunocompetent Adults	50
Prevalence and Patient Characteristics of Ectodermal Dysplasias in Denmark	49
Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis	47
Novel Treatments for Chronic Erythema Multiforme Inform Translational Science and Disease Pathogenesis	45
Assessment of Cutaneous Vasculitis and Quality of Life	45
Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia	44
Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab	43
Current State of Dermatology Mobile Applications With Artificial Intelligence Features	43
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records	42
Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults	42
Disordered Eating in Hidradenitis Suppurativa	42
COVID-19 as a Risk Factor For Autoimmune Skin Disease	41
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database	41
ALK-Positive Histiocytosis—A Distinct Histiocytic Entity Deserving Recognition—Reply	40
Cooling Research Fever in Dermatology—The Role of Community Service—Reply	40
Considerations Regarding Mohs Surgery for Early-Stage Merkel Cell Carcinoma	39
The Quest for a More Accurate Diagnosis of Cellulitis	39
Antihypertensive Medications and Eczematous Dermatitis in Older Adults	38
Serum Immunoglobulin G Levels and Nicastrin Variation in Hidradenitis Suppurativa	38
Methotrexate and Interstitial Lung Disease—Reply	38
Treatment of Severe Dermatitis, Multiple Allergies, and Metabolic Wasting With Dupilumab	37
Validation of the 2022 National Comprehensive Cancer Network Risk Stratification for Cutaneous Squamous Cell Carcinoma	37
Federated Learning for Decentralized Artificial Intelligence in Melanoma Diagnostics	36
JAMA Dermatology	36
Alectinib In the Treatment of Systemic Juvenile Xanthogranuloma of Infancy With ALK Translocation	35
Spesolimab Response in a Patient With Steroid-Resistant Sweet Syndrome	35
Clinical Evidence on “Watchful Waiting” in Basal Cell Carcinoma	35
Errors in Abstract, Results, and Table 1	35
Clinical Characteristics Associated With Response to Biologics in the Treatment of Psoriasis	34
Communication Between Dermatologists and Dermatopathologists via the Pathology Requisition	34
Mohs Surgery vs Wide Local Excision in Primary High-Stage Cutaneous Squamous Cell Carcinoma	34
Validation of Case Identification for Melasma Using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision Codes	34
Trends in the Prevalence of Eczema Among US Children by Age, Sex, Race, and Ethnicity From 1997 to 2018	34
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis—Coordinating Research Priorities to Move the Field Forward	33
Reexamining Medication Impact in Hidradenitis Suppurativa and Pregnancy—Reply	33
Rapid Improvement in Refractory Acute Generalized Exanthematous Pustulosis With Spesolimab	33
Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones	32
Lesbian, Gay, Bisexual, and Transgender Identity and Disclosure Among Dermatologists in the US	31
Foscarnet-Induced Penile Ulceration	30
Numerous Angiomatous Lesions in an Infant	30
Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa	30
Cardiovascular and Venous Thromboembolic Risk With JAK Inhibitors in Immune-Mediated Inflammatory Skin Diseases	30

Errors in Figure 2 and Table 2 Footnotes	29
A Tribute to Samuel Moschella	29
Error in Figure 1	29
Chloracne	29
A Firm Pigmented Plaque on the Forearm of a Child	29
JAMA Dermatology Peer Reviewers in 2022	28
Chemotherapy-Induced Pseudocellulitis Without Prior Radiation Exposure	28
Association of Different Prescribing Patterns for Oral Corticosteroids With Fracture Preventive Care Among Older Adults in the UK and Ontario	28
Oral Lichenoid Lesions Associated With Mediastinal Mass and Hypogammaglobulinemia in a Middle-aged Man	28
Incidence of and Risk Factors for Keratinocyte Carcinoma After Pediatric Solid Organ Transplant	28
Incorporating Social Determinants of Health Into Medical Decision-making—Implications for Dermatology	28
Research Fever in Dermatology—A Symptom of a Larger Problem	28
Error in Table	27
Legislative Efforts Restricting Care for Transgender People	27
A Case of Unilateral Focal Hyperkeratosis	27
JAMA Dermatology	27
Billing Patterns and Geographic Distribution of Dermatologist-Dermatopathologists in the US From 2013 to 2017	27
Association of Sun-Protective Behaviors With Bone Mineral Density and Osteoporotic Bone Fractures in US Adults	26
Incidence and Prevalence of Morphea	26
Risk of New-Onset and Recurrent Depression and Anxiety Among Patients With Hidradenitis Suppurativa	26
Skin Cancer Risk Factors and Screening Among Asian American Individuals	26
High-Dose Upadacitinib Therapy for Refractory Metastatic Crohn Disease	26
Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea	26
Dermatologist Workforce Mobility	25
Melanoma and Racial Health Disparities in Black Individuals—Facts, Fallacies, and Fixes	25
Safety and Efficacy of Topical Lovastatin Plus Cholesterol Cream vs Topical Lovastatin Cream Alone for the Treatment of Disseminated Superficial Actinic Porokeratosis	25
Evaluation of Watchful Waiting and Tumor Behavior in Patients With Basal Cell Carcinoma	25
Use of Patient-Reported Outcomes in Acne Vulgaris and Rosacea Clinical Trials From 2011 to 2021	25
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body	25
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus	25
The Genomic and Phenotypic Landscape of Ichthyosis	25
CLOVES Syndrome	24
Xeroradiography as a Noninvasive Tool in Diagnosing Calciphylaxis	24
Cytotoxic T-Lymphocyte Antigen–4 Haploinsufficiency Cutaneous Manifestations	24
Epidermolysis Bullosa Pruriginosa Treated With Upadacitinib	24
Error in Table Footnote	24
Use of Reflectance Confocal Microscopy in Equivocal Lesions for the Diagnosis of Melanoma	24
Recurrence Rate of Small Melanoma In Situ on Low-Risk Sites Excised With 5-mm Excisional Margin	24
Differences in Face-to-Face Time Spent With a Dermatologist Among Patients With Psoriasis Based on Race and Ethnicity	24
Errors in Abstract and Results Section	24
Role of Eosinophils in Angiolymphoid Hyperplasia With Eosinophilia	23
Mendelian Randomization for Dermatology Research	23
Outcomes Associated With Neutropenia and Lymphopenia in Epidermal Necrolysis	23
Doxycycline Postexposure Prophylaxis (DoxyPEP) for Bacterial STI Prevention	23
Recurring Papules and Nodules on the Vulva	23
Association of Biologic Treatment in Hidradenitis Suppurativa With Reduced Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio	23
Association of Facial Pustular Neutrophilic Eruption With Messenger RNA–1273 SARS-CoV-2 Vaccine	23
Consent and Identifiability for Patient Images in Research, Education, and Image-Based Artificial Intelligence	23
Successful Treatment of Stimulator of Interferon Genes–Associated Vasculopathy of Infantile Onset SAVI Syndrome With Anifrolumab	22
Skin-Related Quality of Life During Autoimmune Bullous Disease Course	22
Potential Sexual Transmission of Tinea Pubogenitalis From TMVII	22
Clinical and Serological Characterization of Orf-Induced Immunobullous Disease	21
Eruptive Xanthomas	21
Symptoms of Cognitive Impairment Among Children With Atopic Dermatitis	21
Evaluation of Gabapentin and Transforaminal Corticosteroid Injections for Brachioradial Pruritus	21
Evaluation of Thalidomide Treatment of Patients With Chronic Erythema Multiforme	21
Benign Familial Pemphigus in Skin of Color	21
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy	21
Annular Erythematous Eruption in a Pediatric Patient	21
Smooth, Firm, Skin-Colored Papules on the Nasal Dorsum	21
Palmar Fasciitis and Polyarthritis Syndrome	21
Prevalence of Comorbidities Among Pediatric Patients With Hidradenitis Suppurativa	21
Cutaneous Herpetiform Ulcerations as the Presenting Sign of an Acute Aortic Occlusion	21
Sudden Conjunctivitis, Lymphopenia, and Rash Combined With Hemodynamic Changes (SCoRCH) After Trimethoprim-Sulfamethoxazole Use	20
Assessment of Need for Improved Identification of a Culprit Drug in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis	20
Fibromyalgia in Patients With Hidradenitis Suppurativa	20
CLAPO Syndrome	20
The Importance of Hair in Black−White Race Relations	20
Artificial Intelligence and Dermatology	20
Safety and Efficacy of Anti–IL-23 Monoclonal Antibody QX004N for Patients With Psoriasis	20
Projective Personification Approach to the Experience of People With Acne and Acne Scarring—Expressing the Unspoken	19
Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata	19
Evaluation and Treatment of Febrile Ulceronecrotic Mucha-Habermann Disease With Ruxolitinib and Tocilizumab as Guided by Cytokine Profile	19
Differences Between Children and Adults With Hidradenitis Suppurativa	19
Acrodermatitis Enteropathica	19
Characterizing Chronic Cutaneous Immune-Related Adverse Events Following Immune Checkpoint Inhibitors	18
Molecular and Clinical Outcomes After Intravenous Gentamicin Treatment for Patients With Junctional Epidermolysis Bullosa Caused by Nonsense Variants	18
JAMA Dermatology	18
JAMA Dermatology Peer Reviewers in 2024	18
Cost-Utility Analysis of Rituximab vs Mycophenolate Mofetil for the Treatment of Pemphigus Vulgaris	18

Epitope Spreading in Immune Checkpoint Inhibitor–Associated Bullous Pemphigoid	18
Diversity and Career Goals of Graduating Allopathic Medical Students Pursuing Careers in Dermatology	18
Patient Perspectives on the Lived Experience of Acne and Its Treatment Among Adult Women With Acne	18
Comorbidities of Keloid and Hypertrophic Scars Among Participants in UK Biobank	17
Eruptive Acral Nevi Secondary to Treatment With Chemotherapy	17
Lack of Transparency and Potential Bias in Artificial Intelligence Data Sets and Algorithms	17
Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age	17
Content Analysis of Patient-Reported Outcome Measures Used in Patients With Nail Conditions	17
Geographic Distribution and Workforce Diversity of Dermatology Physician Assistants—Reply	17
Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab	17
Granulomatous Cheilitis in a Young Woman	17
Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa	17
Radiation Recall Dermatitis With Bruton Tyrosine Kinase Inhibitor Therapy	16
Patient Perspectives on Living With Severe Prurigo Nodularis	16
Delphi Panel for the Development of Diagnostic Criteria for Metastatic Cutaneous Crohn Disease	16
A Reddish Semitransparent Tumor in an Adolescent Girl	16
Response of Severe Lupus Miliaris Disseminatus Faciei to Treatment With Ruxolitinib Cream	16
Rubella Virus–Associated Granulomas in Immunocompetent Adults—Possible Implications	16
Improvement of Hailey-Hailey Disease With Topical Cinacalcet, 3%, Ointment	16
Diagnosis of Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors	15
Nonmelanoma Skin Cancer in Patients Older Than Age 85 Years Presenting for Mohs Surgery	15
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis	15
Treatment of Netherton Syndrome With Abrocitinib	15
Adjuvant Immunotherapy in Stage II Melanoma—Further Risk Stratification is Needed	15
Safety and Effectiveness of Oral Nutraceuticals for Treating Acne	15
Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma	15
Genetic Susceptibility to Hidradenitis Suppurativa and Predisposition to Cardiometabolic Disease	15
Granulomatosis With Polyangiitis Presenting With Strawberry Gums	15
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis	15
Prevalence of Pretreatment Testing Recommended for Patients With Chronic Inflammatory Skin Diseases	15
JAMA Dermatology	14
UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome	14
JAMA Dermatology	14
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis	14
Pigmentary Changes in a Woman With Oral Lichen Planus	14
Generalized Micropapular Eruption in a Teenager	14
Association Between Psoriasis and Nonalcoholic Fatty Liver Disease Among Outpatient US Adults	14
Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF)	14
JAMA Dermatology	14
Reanalysis Following Removal of Participants From 1 Site in Multicenter Trial of Upadacitinib vs Dupilumab for Atopic Dermatitis	13
Risk of Hematologic Cancer in Patients With Undifferentiated Pruritus	13
Error in Box	13
Patterns of Atopic Eczema Disease Activity From Birth Through Midlife in 2 British Birth Cohorts	13
Chronic Mucocutaneous Candidiasis Due to STAT1 Gene Variant	13
Incidence and Factors Associated With Second Primary Invasive Melanoma in Norway	13
Pyoderma Gangrenosum	13
Olmsted Syndrome	13
Response of Widespread Generalized Essential Telangiectasia Following Treatment With Oral Dabigatran	13
Tuberculous Mastitis	13
Cutaneous Adverse Events and Cancer Survival Prognosis With Immune Checkpoint Inhibitor Treatment	13
Perspectives and Strategies to Minimize Harm From Melanoma Diagnosis	13
Cost-Effectiveness Analysis of 3D Total-Body Photography for People at High Risk of Melanoma	12
Intertriginous Xanthomas—Pathognomonic Cutaneous Markers of Homozygous Familial Hypercholesterolemia	12
Gene-Environment Interaction Between CYP1B1 and Oral Contraception on Frontal Fibrosing Alopecia	12
Checklist for Evaluation of Image-Based Artificial Intelligence Reports in Dermatology	12
Improvement of Mortality Prognostication in Patients With Epidermal Necrolysis	12
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children	12
Evidence-Based Clinical Practice Guidelines for Laser-Assisted Drug Delivery	12
Treatment of Suspected Rubella Virus–Associated Granulomatous Dermatitis With Adalimumab	12
Treatment of Porokeratosis Ptychotropica With a Topical Combination of Cholesterol and Simvastatin	12
Clinical Features and Outcomes of Black Patients With Melanoma	12
Clinical Associations of Degos-Like Lesions in Patients With Systemic Sclerosis	12
Hypertrophic Tongue Papillae in Cowden Syndrome/PTEN Hamartoma Tumor Syndrome	12
Genetic Variants Associated With Hidradenitis Suppurativa	12
Perspectives on Use of the Cutaneous Direct Immunofluorescence Assay—Reply	11
Arc-Shaped Furrow on the Forehead Extending From Linear Alopecia on the Vertex	11
Intralesional Certolizumab for Refractory Lupus Pernio	11
Clinical Data on Laboratory Testing for Patients Taking Systemic Immunomodulatory Agents	11
Onychomycosis	11
The Consideration of Cyclosporine in the Treatment of Stevens-Johnson Syndrome	11
Relevance of Human Herpesvirus 6 Reactivation in Drug Rash With Eosinophilia and Systemic Symptoms—Reply	11
Association Between Homelessness and Group A Streptococcus Skin and Soft Tissue Infections Among Hospitalized Dermatology Consult Patients	11
Trichophyton mentagrophytes Internal Transcribed Spacer Genotype VIII	11
Reanalysis of Study After Removal of Participants in 1 Trial of Upadacitinib for Atopic Dermatitis	11
Genital and Perigenital “W”-Shaped Telangiectasias in Women With Limited Cutaneous Systemic Sclerosis	11
JAMA Dermatology	11
JAMA Dermatology’s Commitment to Diversity, Equity, and Inclusion	11
Evaluation of Clinical Relevance and Biological Effects of Antirituximab Antibodies in Patients With Pemphigus	11
Why Increased Diversity in Dermatologic Clinical Trials Is Not Inherently Ethical—An Evidence-Based, Community-Engaged Approach to Diverse Trial Recruitment	10
Sarcoidosis-Specific Cutaneous Lesion Distribution in Clinical Assessment for Cardiac Sarcoidosis	10
Destructive Facial Plaque and Palatal Perforation in a Middle-Aged Woman	10
Melanoma Epidemiology—Pivoting to Low- and Middle-Income Countries	10
Cutaneous Anthrax	10
Factors Driving the Risk of Cognitive Impairment in Children With Atopic Dermatitis	10
Salt and Atopic Dermatitis—Reply	10
Association of Tumor Characteristics With Insurance Type Among Patients Undergoing Mohs Micrographic Surgery for Nonmelanoma Skin Cancer	10
Leprosy—Insufficient Evidence for Monthly Multidrug Therapy—Reply	10
Association Between Low-Dose Methotrexate Exposure and Melanoma	10
Risk of All-Cause Mortality, Cardiovascular Disease Mortality, and Cancer Mortality in Patients With Bullous Pemphigoid	10
Validation of the Acne Core Outcomes Research Network Patient Global Assessment for Acne	10
Measuring the Carbon Footprint of Dermatology	10
Tzanck Smear of Ulcerated Plaques	10
Hunter Syndrome	10
Prevention of Skin Cancers With Topical Calcipotriol and Fluorouracil in Patients With Xeroderma Pigmentosum	10
Botulinum Toxin A for the Treatment of Yellow Nail Syndrome and Palmar Primary Hyperhidrosis	10